Lee, Yonghyun http://orcid.org/0000-0002-2728-9698
Shinn, Jongyoon
Xu, Cheng
Dobson, Hannah E. http://orcid.org/0000-0003-1246-880X
Neamati, Nouri
Moon, James J. http://orcid.org/0000-0003-2238-2372
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (R01DE030691, R01DE031951)
U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK125087)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS122536)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA271799, U01CA210152)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
National Research Foundation of Korea (NRF) funded by the Ministry of Education
Article History
Received: 1 May 2022
Accepted: 20 July 2023
First Online: 8 August 2023
Competing interests
: J.J.M. declares financial interests for board membership, as a paid consultant, for research funding, and/or as an equity holder in EVOQ Therapeutics and Saros Therapeutics. The University of Michigan has a financial interest in EVOQ Therapeutics, Inc. The remaining authors declare no competing interests.